The CAG/Polyglutamine Tract Diseases: Gene Products and Molecular Pathogenesis

Beena T Koshy; Huda Y Zoghbi

doi:10.1111/j.1750-3639.1997.tb00894.x

. 2008 Jan 28;7(3):927–942. doi: 10.1111/j.1750-3639.1997.tb00894.x

The CAG/Polyglutamine Tract Diseases: Gene Products and Molecular Pathogenesis

Beena T Koshy ^1,^✉, Huda Y Zoghbi ^1,^✉

PMCID: PMC8098410 PMID: 9217976

Abstract

In the past few years, a new type of genetic mutation, expansion of trinucleotide repeats, has been shown to cause neurologic disease. This new class of mutations was first identified in 1991 as the underlying genetic defect in spinal and bulbar muscular atrophy and the fragile X syndrome, and in recent years, trinucleotide repeat expansions have been found to be the causative mechanism in 10 other neurologic diseases. These mutations are produced by heritable unstable DNA and are termed “dynamic mutations” because of changes in the number of repeat units inherited from generation to generation. In the normal population, these repeat units, although polymorphic, are stably inherited.

To date four types of trinucleotide repeat expansions have been identified: (1) long cytosine‐guanine‐guanine (CGG) repeats in the two fragile X syndromes (FRAXA and FRAXE), (2) long cytosine‐thymine‐guanine (CTG) repeat expansions in myotonic dystrophy, (3) long guanine‐adenine‐adenine repeat expansions in Friedreich's ataxia and (4) short cytosine‐adenine‐guanine repeat expansions (CAG) which are implicated in eight neurodegenerative disorders and are the focus of this review.

Diseases that are caused by trinucleotide repeat expansions exhibit a phenomenon called anticipation that can not be explained by conventional Mendelian genetics. Anticipation is defined as increase in the severity of disease with an earlier age of onset of symptoms in successive generations [5, 50, 57, 106]. Anticipation is often influenced by the sex of the transmitting parent, and for most CAG repeat disorders, the disease is more severe when paternally transmitted. The severity and the age of onset of the disease have been correlated with the size of the repeats on mutant alleles, with the age of onset being inversely correlated with the size of the expansion.

In all eight disorders caused by CAG repeat expansion, the repeat is located within the coding region of the gene involved and in all cases it is translated into a stretch of polyglutamines in the respective proteins. All the proteins are unrelated outside of the polyglutamine stretch and most are novel with exception of the androgen receptor and the voltage gated α1A calcium channel, which are mutated in spinal and bulbar muscular atrophy and spinocerebellar ataxia type 6. It is intriguing that the proteins are ubiquitously expressed in both peripheral and nervous tissue but in each disorder only a select population of nerve cells are targeted for degeneration as a consequence of the expanded CAG repeat. Current thinking among scientists working on the molecular mechanisms of neurodegeneration in these diseases is that the presence of an expanded polyglutamine confers a gain of function onto the involved protein. To understand the mechanisms underlying the pathogenesis of these diseases, investigators have turned to generating transgenic mice which recapitulate some of the features of the human disease and hence are excellent model systems to study the progression of the disease in vivo.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

References

1. Albin RL, Tagle DA (1995) Genetics and molecular biology of Huntington's disease. Trends Neurosci. 18:11–14. [DOI] [PubMed] [Google Scholar]
2. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilman J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA, Graham RK, Hayden MR (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet. 4:398–403. [DOI] [PubMed] [Google Scholar]
3. Arbizu T, Santamaria J, Gomez JM, Quilez A, Serra JP (1983) A family with adult spinal and bulbar muscular atrophy, X‐linked inheritance and associated testicular failure. J. Neurol Sci. 59:371–382. [DOI] [PubMed] [Google Scholar]
4. Aronin N, Chase K, Young C, Sapp E, Schwarz C, Matta N, Kornreich R, Landwehrmeyer B, Bird E, Beal MF, Vonsattel J‐P, Smith T, Carraway R, Boyce FM, Young AB, Penney JB, DiFiglia M (1995) CAG Expansion Affects the Expression of Mutant Huntingtin in the Huntington's Disease Brain. Neuron 15:1193–1201. [DOI] [PubMed] [Google Scholar]
5. Ashizawa T, Dubel JR, Dunne PW, Dunne CJ, Fu YH, Pizzuti A, Caskey CT, Boerwinkle E, Perryman MB, Epstein HF, Hejtmancik JF (1992) Anticipation in myotonic dystrophy: II. Complex relationships between clinical findings and structure of the GCT repeat. Neur. 42:1877–1883. [DOI] [PubMed] [Google Scholar]
6. Ballabio A, Zoghbi HY (1995) Additional topics. In: Scriver CR, Beaudet AL, Sly WS, Valk D (eds) The metabolic basis of inherited disease. McGraw‐Hill, New York . [Google Scholar]
7. Banfi S, Chung MY, Kwiatkowski TJ, Jr. , Ranum LP, McCall AE, Chinault AC, Orr HT, Zoghbi HY (1993) Mapping and cloning of the critical region for the spinocerebellar ataxia type 1 gene (SCA1) in a yeast artificial chromosome contig spanning 1.2 Mb. Genomics 18:627–635. [DOI] [PubMed] [Google Scholar]
8. Banfi S, Servadio A, Chung M‐y, Kwiatkowski TJ Jr, McCall AE, Duvick LA, Shen Y, Roth EJ, Orr HT, Zoghbi HY (1994) Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nature Genet. 7:513–519. [DOI] [PubMed] [Google Scholar]
9. Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM (1996) Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc. Natl. Acad. Sci USA 93:5037–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
10. Barbeau A, Roy M, Cunha L, de Vincente AN, Rosenberg RN, Nyhan WL, MacLeod PM, et al (1984) The natural history of Machado‐Joseph disease: an analysis of 138 personally examined cases. Can. J. Neurol. Sci. 11:510–525. [DOI] [PubMed] [Google Scholar]
11. Baxendale S, MacDonald ME, Mott R, Francis F, Lin C, Kirby SF, James M, Zehetner G, Hummerich H, Valdes J, Collins FS, Deaven LJ, Gusella JF, Lehrach H, Bates GP (1993) Acosmid contig and high resolution restriction map of the 2 megabase region containing the Huntington's disease gene. Nature Genet. 4:181–186. [DOI] [PubMed] [Google Scholar]
12. Bebin EM, Bebin J, Currier RD, Smith EE, Perry TL (1990) Morphometric studies in dominant olivopontocerebellar atrophy. Arch. Neurol. 47:188–192. [DOI] [PubMed] [Google Scholar]
13. Bharucha N, Bharucha E, Bhabha S (1986) Machado‐Joseph Azorean disease in India. Arch. Neurol. 43:142–144. [DOI] [PubMed] [Google Scholar]
14. Biancalana V, Serville F, Pommier J, Julien J, Hanauer A, Mandel JL (1992) Moderate instability of the trinucleotide repeat in spinobulbar muscular atrophy. Hum. Mol. Genet. 1:255–258. [DOI] [PubMed] [Google Scholar]
15. Bingham PM, Scott MO, Wang S, McPhaul MJ, Wilson EM, Garbern JY, Merry DE, Fischbeck KH (1995) Stability of an expanded trinucleotide repeat in the androgen receptor gene in trangenic mice. Nature Genet. 9:191–196. [DOI] [PubMed] [Google Scholar]
16. Bird ED (1978) The brain in Huntington's chorea. Psycol. Med. 8:357–360. [DOI] [PubMed] [Google Scholar]
17. Bozza A, Malagu S, Caizolari E, Novelletto A, Pavoni M, del Senno L (1995) Expansion of a (CAG)n repeat region in a sporadic case of HD. Acta Neurol Scand. 92:132. [DOI] [PubMed] [Google Scholar]
18. Brown CJ, Goss SJ, Lubahn DB, Joseph DR, Wilson EM, French FS, Willard HT (1989) Androgen receptor locus on the X chromosome: Regional localization to Xq11–12 and description of a DNA polymorphism. Amer. J. Hum. Genet. 44:264–269. [PMC free article] [PubMed] [Google Scholar]
19. Bruyn GW, Bots GTA, Dom R (1979) Huntington's chorea: Current neuropathological status. Adv. Neurol. 23:83–93. [Google Scholar]
20. Burke JR, Enghild JJ, Martin ME, Jou Y‐S, Myers RM, Roses AD, Vance JM, Strittmatter WJ (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med. 2:347–350. [DOI] [PubMed] [Google Scholar]
21. Burke JR, Wingfield MS, Lewis KE, Roses AD, Lee JE, Hulette C, Pericak‐Vance MA, Vance JM (1994) The Haw River Syndrome: Dentatorubropallidoluysian atrophy (DRPLA) in an African‐American family. Nature Genet. 7:521–524. [DOI] [PubMed] [Google Scholar]
22. Burright EN, Clark HB, Servadio A, Matilla T, Feddersen RM, Yunis WS, Duvick LA, Zoghbi HY, Orr HT (1995) SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82:937–948. [DOI] [PubMed] [Google Scholar]
23. Chang C, Kokontis J, Liao S (1988) Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc. Natl. Acad. Sci. USA 85:7211–7215. [DOI] [PMC free article] [PubMed] [Google Scholar]
24. Chong SS, McCall AE, Cota J, Subramony SH, Orr HT, Zoghbi HY (1995) Gametic and somatic tissue‐specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1. Nature Genet. 10:344–350. [DOI] [PubMed] [Google Scholar]
25. Chung M‐y, Ranum LPW, Duvick L, Servadio A, Zoghbi HY, Orr HT (1993) Analysis of the CAG repeat expansion in spinocerebellar ataxia type I: evidence for a possible mechanism predisposing to instability. Nature Genet. 5:254–258. [DOI] [PubMed] [Google Scholar]
26. Currier RD, Glover G, Jackson JF, Tipton AC (1972) Spinocerebellar ataxia: study of a large kindred. Neurology 22:1040–1043. [DOI] [PubMed] [Google Scholar]
27. Davis MB, Bateman D, Quinn NP, Marsden CD, Harding AE (1994) Mutation analysis in patients with possible but apparently sporadic Huntington's disease. Lancet 344:714. [DOI] [PubMed] [Google Scholar]
28. De Rooij KE, Dorsman JC, Smoor MA, Den Dunnen JT, Van Ommen G‐JB (1996) Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. Hum. Mol. Genet. 5:1093–1099. [DOI] [PubMed] [Google Scholar]
29. DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C, Martin E, Vonsattel J‐P, Carraway R, Reeves SA, Boyce FM, Aronin N (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14:1075–1081. [DOI] [PubMed] [Google Scholar]
30. Durr A, Dode C, Hahn V, Pecheux C, Pillon B, Feingold J, Kaplan JC, Agid Y, Brice A (1995) Diagnosis of “sporadic” Huntington's disease. J. Neurol. Sci. 129:51. [DOI] [PubMed] [Google Scholar]
31. Durr A, Smadja D, Cancel G, Lezin A, Stevanin G, Mikol J, Bellance R, Buisson G‐G, Chneiweiss H, Dellanave J, Agid Y, Brice A, Vernant J‐C (1995) Autosomal dominant cerebellar ataxia type 1 in Martinique (French West Indies): Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 118:1573–1581. [DOI] [PubMed] [Google Scholar]
32. Durr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, Chneiweiss H, Benomar A, Lyon‐Caen O, Julien J, Serdaru M, Penet C, Agid Y, Brice A (1996) Spinocerebellar ataxia 3 and machado‐joseph disease: Clinical, molecular and neuropathological features. Ann. Neurol. 39:490–499. [DOI] [PubMed] [Google Scholar]
33. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M, Gray J, Conneally P, Young A, Penney J, Hollingsworth Z, Shoulson I, Lazzarini A, Falek A, Koroshetz W, Sax D, Bird E, Vonsattel J, Bonilla E, Alvir J, Bickham Conde J, Cha J‐H, Dure L, Gomez F, Ramos M, Sanchez‐Ramos J, Snodgrass S, de Young M, Eexler N, Moscowitz C, Penchaszadeh G, MacFarlene H, Anderson M, Jenkins B, Srinidhi J, Barnes G, Gusella J, MacDonald M (1993) Trinucleotide repeat length and age of onset in Huntington's disease. Nature Genet. 4:387–392. [DOI] [PubMed] [Google Scholar]
34. Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McCeil SM, Ge P, Vonsattel J‐P, Gusella JF, Joyner AL, MacDonald ME (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269:407–410. [DOI] [PubMed] [Google Scholar]
35. Farrer LA (1986) Suicide and attempted suicide in Huntington's disease: implication for preclinical testing of persons at risk. Am. J. Med. Genet. 24:305–311. [DOI] [PubMed] [Google Scholar]
36. Farrer LA, Conneally PM (1987) Predictability of pheno‐type in Huntington's disease. Arch. Neurol. 44:109–113. [DOI] [PubMed] [Google Scholar]
37. Fischbeck KH, Ionasescu V, Ritter AW, Ionasescu R, Davies K, Ball S, Bosch P, Burns T, Hausmanowa‐Petrusewicz I, Borkowska J, Ringel SP, Stern LZ (1986) Localization of the gene for X‐linked spinal muscular atrophy. Neurology 36:1595–1598. [DOI] [PubMed] [Google Scholar]
38. Folstein SE (1989) Huntington's disease. John Hopkins University Press, Baltimore , Maryland . [Google Scholar]
39. Gispert S, Lunkes A, Santos N, Orozco G, Ha‐Hao D, Ratzlaff T, Aguiar J, Torrens I, Heredero L, Brice A, Cancel G, Stevanin G, Vernant J‐C, Durr A, Lepage‐Lezin A, Belal S, Ben‐Hamida M, Pulst S, Rouleau G, Weissenbach J, LePaslier D, Kucherlapati R, Montgomery K, Fukui K, Auburger G (1995) Localization of the candidate gene D‐amino oxidase outside the refined I‐cM region of spinocerebellar ataxia 2. Amer. J. Hum. Genet. 57:972–975. [PMC free article] [PubMed] [Google Scholar]
40. Gispert S, Twills R, Orozco G, Brice A, Weber J, Heredero L, Scheufler K, Riley B, Allotey R, Nothers C, Hillerman R, Lunkes A, Khati C, Stevanin G, Hernandez A, Magarino C, Klockgether T, Durr A, Chneiweiss H, Enczmann J, Farrall M, Beckmann J, Mullan M, Wernet P, Agid Y, Freund H‐J, Williamson R, Auburger G, Chamberlain S (1993) Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23–24.1. Nature Genet. 4:295–299. [DOI] [PubMed] [Google Scholar]
41. Goldberg YP, Kalchman MA, Metzler M, Nasir J, Zeisler J, Graham R, Koide HB, O'Kusky J, Sharp AH, Ross CA, Jirik F, Hayden MR (1996) Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. Hum. Mol. Genet. 5:177–185. [DOI] [PubMed] [Google Scholar]
42. Goldberg YP, Kremer B, Andrew SE, Theilmann J, Graham RK, Squitieri F, Telenius H, Adam S, Sajoo A, Starr E, et al. (1993) Molecular analysis of new mutations for huntington's disease: intermediate alleles and sex of. Nature Genet 5:174–9: 182. [DOI] [PubMed] [Google Scholar]
43. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Bromm M, Kazemi‐Esfarjani P, Thornberry NA, Vaillancourt JP, Hayden MR (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13:442–9. [DOI] [PubMed] [Google Scholar]
44. Greenfield JG (1954) The spino‐cerebellar degenerations. C. C. Thomas, Springfield , IL , pp 112. [Google Scholar]
45. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971–983. [DOI] [PubMed] [Google Scholar]
46. Gusella JF, MacDonald ME (1996) Pathogenic mechanism in Huntington's disease. Quan. Symp. Cold Spring Harbor In press. [Google Scholar]
47. Gusella JF, MaoDonald ME, Ambrose CM, Duyao MP (1993) Molecular genetics of Huntington's disease. Arch. Neurol. 50:1157–1163. [DOI] [PubMed] [Google Scholar]
48. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ortina K, Wallace MR, Sakaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB (1983) A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306:234–238. [DOI] [PubMed] [Google Scholar]
49. Harding AE, Tromas PK, Baraitser M, Bradbury PG, Morgan‐Hughes JA, Ponsford JR (1982) X‐linked recessive bulbospinal neuronopathy: A report of ten cases. J. Neurol. Neurosurg. Psychiatry 45:1012–1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
50. Harper PS (1989) Myotonic Dystrophy. In: Saunders WB (ed.) Vol. 2, London . [Google Scholar]
51. Harper PS, Morris MJ, Quarrell O, Shaw DJ, Tyler A, Youngman S (1991) Huntington's disease. W.B. Saunders, Philadelphia . [Google Scholar]
52. Hayden MR (1981) Huntington's chorea. Springer‐Verlag, New York . [Google Scholar]
53. Hayden MR, Kremer B (1995) Huntington Disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease. Vol. III. McGraw‐Hill, Inc., New York , pp 4483–4510. [Google Scholar]
54. Hayden MR, Soles JA, Ward RH (1985) Age of onset in siblings of persons with juvenile Huntington's disease. Clin. Genet. 28:100–105. [DOI] [PubMed] [Google Scholar]
55. Hodgson JG, Smith DJ, McCutcheon K, Koide HG, Nishiyama K M.B. D, Stevens ME, Bissada N, Nasir J, Kanazawa I, Disteche CM, Rubin EM, M.R. H (1996) Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum. Mol. Genet. 5:1875–1885. [DOI] [PubMed] [Google Scholar]
56. Hoogeveen AT, Willemsen R, Meyer N, de Rooij KE, Roos RAC, van Ommen G‐JB, Galjaard H (1993) Characterization and localization of the Huntington disease gene product. Hum. Mol. Genet. 2:2069–2073. [DOI] [PubMed] [Google Scholar]
57. Höweler CJ, Busch HFM, Geraedts JPM, Niermeijer MF, Staal A (1989) Anticipation in myotonic dystrophy: fact or fiction. Brain 112:779–797. [DOI] [PubMed] [Google Scholar]
58. Huntington G (1872) On chorea. Med. Surg. Reporter 26:317–321. [Google Scholar]
59. Hyslop PS, Rogaeva E, Huterer J, Tsuda T, Santos J, Haines JL, Schlumpf K, Rogaev EI, Liang Y, McLachlan DR, Kennedy J, Weissenbach J, Billingsley GD, Cox DW, Lang AE, Wherrett JR (1994) Machado‐Joseph disease in pedigrees of Azorean descent is linked to chromosome 14. Am. J. Hum. Genet. 55:120–125. [PMC free article] [PubMed] [Google Scholar]
60. Igarashi S, Tanno Y, Onodera O, Yamazaki M, Sato S, Ishikawa A, Miyatani N, Nagashima M, Ishikawa Y, Sahashi K, Ibi T, Miyatake T, Tsuji S (1992) Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology 42:2300–2302. [DOI] [PubMed] [Google Scholar]
61. Ihara T, Sasaki H, Wakisaka A, Takada A, Yoshiro K (1994) Genetic heterogeneity of dominantly inherited olivopontocerebellar atrophy (OPCA) in the Japanese: linkage study of two pedigrees and evidence for the disease locus on chromosome 12q (SCA2). Human Genetics 39:305–313. [DOI] [PubMed] [Google Scholar]
62. Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Gamier J‐M, Weber C, Mandel J‐L (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats and high instability. Nature Genet. 14:285–291. [DOI] [PubMed] [Google Scholar]
63. Jackson JF, Currier RD, Terasaki PI, Morton NE (1977) Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N. Engl. J. Med. 296:1138–1141. [DOI] [PubMed] [Google Scholar]
64. Jodice C, Malaspina P, Persichetti F, Novelletto A. Spadaro M, Giunti P, Morocutti C, Terrena'o L, Harding AE, Frontali M (1994) Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar ataxia 1. Amer. J. Hum. Genet. 54:959–965. [PMC free article] [PubMed] [Google Scholar]
65. Jou YS, Myers RM (1995) Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum. Mol. Genet. 4:465–9. [DOI] [PubMed] [Google Scholar]
66. Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, Goldberg YP, Gietz RD, Pickart CM, Hayden MR (1996) Huntingtin is ubiquitinated and interacts with a specific ubiquitin‐conjugating enzyme. J. Biol. Chem. 271: 19385–94. [DOI] [PubMed] [Google Scholar]
67. Kalchman MA, Koide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K, Kazemi‐Esfarjani P, Lynn FC, Wellington C, Metzler M, Goldberg YP, Kanazawa I, Gietz RD, Hayden MR (1997) HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane‐associated huntingtin in the brain. Nature Genet. 16:44–53. [DOI] [PubMed] [Google Scholar]
68. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I, Kimura J. Narumiya S, Kakizuka A (1994) CAG expansions in a novel gene for Machado‐Joseph disease at chromosome 14q32.1. Nature Genet. 8:221–227. [DOI] [PubMed] [Google Scholar]
69. Kennedy WR, Alter M, Sung JH (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset ‐ A sex‐linked recessive trait. Neurology 18:671–680. [DOI] [PubMed] [Google Scholar]
70. Koeppen AH, Barron KD (1984) The neuropathology of olivopontocerebellar atrophy. In: Duvoisin RC, Plaitakis A (eds) The olivopontocerebellar atrophies. Raven, New York , pp 13–38. [PubMed] [Google Scholar]
71. Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, Takahashi H, Kondo R, Ishikawa A, Hayashi T, Saito M, Tomoda A, Miike T, Naito H, Ikuta F, Tsuji S (1994) Unstable expansion of CAG repeat in hereditary dentatorubral‐pallidoluysian atrophy (DRPLA). Nature Genet. 6:9–13. [DOI] [PubMed] [Google Scholar]
72. Koshy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY (1996) Spinocerebellar ataxia type‐1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde‐3‐phosphate dehydrogenase. Hum. Mol. Genet. 5:1311–1318. [DOI] [PubMed] [Google Scholar]
73. Kwiatkowski TJ Jr, Orr HT, Banfi S, McCall AE, Jodice C, Persichetti F, Novelletto A, LeBorgne‐Demarquoy F, Duvick LA, Frontali M, Subramony SH, Beaudet AL, Terrenato L, Zoghbi HY, Ranum LPW (1993) The gene for autosomal dominant spinocerebellar ataxia (SCA1) maps centromeric to D6S89 and shows no recombination, in nine large kindreds, with a dinucleotide repeat at the AM10 locus. Am. J. Hum. Genet. 53:391–400. [PMC free article] [PubMed] [Google Scholar]
74. La Spada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa‐Petrusewicz I, Yee W‐C, Fischbeck KH (1992) Meiotic stability and genotype‐phenotype correlation of the trinucleotide repeat in X‐linked spinal and bulbar muscular atrophy. Nature Genet. 2:301–304. [DOI] [PubMed] [Google Scholar]
75. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck H (1991) Androgen receptor gene mutations in X‐linked spinal and bulbar muscular atrophy. Nature 352:77–79. [DOI] [PubMed] [Google Scholar]
76. Landwehrmeyer GB, McNeil SM, Dure LSt, Ge P, Aizawa H, Huang Q, Ambrose CM, Duyao MP, Bird ED, Bonilla E, et al. (1995) Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann. Neurol. 37:218–30. [DOI] [PubMed] [Google Scholar]
77. Leeflang EP, Zhang L, Tavare S, Hubert R, Srinidhi J, MacDonald ME, Myers RH, de Young M, Wexler NS, Guseila JF, et al. (1995) Single sperm analysis of the trinucleotide repeats in the Huntington's disease gene: quantification of the mutation frequency spectrum. Hum. Mol. Genet. 4:1519–26. [DOI] [PubMed] [Google Scholar]
78. Lezin A, Cancel G, Stevanin G, Smadja D, Vernant JC, Durr A, Martial J, Buisson GG, Bellance R, Chneiweiss H, Agid Y, Brice A (1996) Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): genetic analysis of three unrelated SCA2 families. Human Genetics 97:671–676. [DOI] [PubMed] [Google Scholar]
79. Li S‐H, Schilling G, Young WSI, Li X‐J, Margolis RL, Stine OC, Wagster MV, Abbott MH, Franz ML, Ranen NG, Foistein SE, Hedreen JC, Ross CA (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11:985–993. [DOI] [PubMed] [Google Scholar]
80. Li X‐J, Li S‐H, Sharp AH, Nucifora FCJ, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A hunt‐ingtin‐associated protein enriched in brain with implications for pathology. Nature 378:398–402. [DOI] [PubMed] [Google Scholar]
81. Lopes‐Cendes I, Andermann E, Rouleau GA (1994) Evidence for the existence of a fourth dominantly inherited spinocerebellar ataxia locus. Genomics 21:270–274. [DOI] [PubMed] [Google Scholar]
82. Lorenzetti D, Bohlega S, Zoghbi HY (1997) The expansion of the CAG repeat in the ataxin‐2 gene is a frequent cause of autosomal dominant spinocerebellar ataxia. Neurology (in press). [DOI] [PubMed] [Google Scholar]
83. MacDonald ME, Barnes G, Srinidhi J, Duyao MP, Ambrose CM, Myers RH, Gray J, Connealy PM, Young A, Penney J, Shoulson J, Hollingsworth Z, Koroshetz W, Bird E, Vonsattel JP, Bonilla E, Moscowitz C, Penchaszadeh G, Brzustowicz L, Alvir J, Bickjam Conde J, Cha J‐H, Dure L, Gomez F, Ramos‐Arroyo M, Sanchez‐Ramos J, Snodgrass SR, de Young M, Wexler NS, MacFarlane H, Anderson MA, Jenkins B, Guseila JF (1993) Gametic but not somatic instability of CAG repeat length in Huntington's disease. J. Med. Genet. 30:982–986. [DOI] [PMC free article] [PubMed] [Google Scholar]
84. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, G.P. B (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493–506. [DOI] [PubMed] [Google Scholar]
85. Martin JB, Guseila JF (1986) Huntington's disease: pathogenesis and management. N. Engl. J. Med. 315:1267–1276. [DOI] [PubMed] [Google Scholar]
86. Maruyama H, Nakamura S, Matsuyama Z, Sakai T, Doyu M, Sobue G, Seto M, Tsujihata M, Oh‐i T, Nishio T, Sunohara N, Takahashi R, Hayashi M, Nishino I, Ohtake T, Oda T, Nishimura M, Saida T, Matsumoto H, Baba M, Kawaguchi Y, Kakizuka A, Kawakami H (1995) Molecular features of the CAG repeats and clinical manifestation of Machado‐Joseph disease. Hum. Mol. Genet. 4:807–812. [DOI] [PubMed] [Google Scholar]
87. Matilla T, McCall A, Subramony SH, Zoghbi HY (1995) Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado‐Joseph disease. Ann. Neurol. 38:68–72. [DOI] [PubMed] [Google Scholar]
88. Matilla T, Volpini V, Gem's D, Rosell J, Corral J, Davalos A, Molins A, Estivill X (1993) Presymptomatic analysis of spinocerebellar ataxia type 1 (SCA1) via the expansion of the SCA1 CAG‐repeat in a large pedigree displaying anticipation and parental male bias. Hum. Mol. Genet. 2:2123–2128. [DOI] [PubMed] [Google Scholar]
89. Mhatre AN, Trifiro MA, Kaufman M, Kazemi‐Esfarjani P, Figlewicz D, Rouleau G, Pinsky L (1993) Reduced transcriptional regulatory competence of the androgen receptor in X‐linked spinal and bulbar muscular atrophy. Nature Genet. 5:184–188. [DOI] [PubMed] [Google Scholar]
90. Miwa S (1994) Triplet repeats strike again. Nature Genet. news & views 6:3–4. [DOI] [PubMed] [Google Scholar]
91. Myers RH, MacDonald ME, Koroshetz WJ, Duyao MP, Ambrose CM, Taylor SAM, Barnes G, Srinidhi J, Lin CS, Whaley WL, Lazzarini AM, Schwarz M, Wolff G, Bird ED, Vonsattel J‐PG, Guseila JF (1993) De novo expansion of a (CAG)n repeat in sporadic Huntington's disease. Nature Genet. 5:168–173. [DOI] [PubMed] [Google Scholar]
92. Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, Takedo T, Tadokoro K, Kondo I, Muruyama N, Tanaka Y, Kikushima H, Umino K, Kurosawa H, Furukawa T, Nihei K, Inoue T, Sano A, Komure O, Takahashi M, Yoshizawa T, Kanazawa I, Yamada M (1994) Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genet. 6:14–18. [DOI] [PubMed] [Google Scholar]
93. Naito H, Oyanagi S (1982) Familial myoclonus epilepsy and choreoathetosis: Hereditary dentatorubral‐pallidoluysian atrophy. Neurology 32:798–807. [DOI] [PubMed] [Google Scholar]
94. Nakano KK, Dawson DM, Spence A (1972) Machado disease: A hereditary ataxia in Portuges emigrants to Massachusetts. Neurology 22:49–55. [DOI] [PubMed] [Google Scholar]
95. Nance MA (1996) Huntington disease‐another chapter rewritten [editorial]. Amer. J. Hum. Genet. 59:1–6. [PMC free article] [PubMed] [Google Scholar]
96. Nasir J, Floresco SB, O'Kusky JR, Diewert VM, Richman JM, Zeisler J, Borowski A, Marth JD, Phillips AG, Hayden MR (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morpholcgical changes in heterozygotes. Cell 81:811–823. [DOI] [PubMed] [Google Scholar]
97. Nino HE, Noreen HJ, Dubey DP (1980) A family with hereditary ataxia: HLA typing. Neurology 30:12–20. [DOI] [PubMed] [Google Scholar]
98. Norremolle A, Riess O, Epplen JT, Fenger K, Hasholt L, Sorensen SA (1993) Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families. Hum. Mol. Genet. 2:1475–1476. [DOI] [PubMed] [Google Scholar]
99. Novelletto A, Persichetti F, Sabbadini G, Mandich P, Bellone E, Ajmar F, Pergola M, Del Senno L, MacDonald ME, Guseila JF, Frontali M (1994) Analysis of the trinucleotide repeat expansion in Italian families affected with Huntington disease. Hum. Mol. Genet. 3:93–98. [DOI] [PubMed] [Google Scholar]
100. Onodera O, Oyake M, Takano H, Ikeuchi T, Igarashi S, Tsuji S (1995) Molecular cloning of a full‐length cDNA for dentatorubral‐pallidoluysian atrophy and regional expressions of the expanded alleles in the CNS. Am. J. Hum. Genet 57:1050–1060. [PMC free article] [PubMed] [Google Scholar]
101. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SMG, Lamerdin JE, Mohrenweiser HW, De Bulman, Ferrari M, Haan J, Lindhout D, van Ommen G‐JB, Hofker MH, Ferrari MD, Frants RR (1996) Familial Hemiplegic Migraine and Episodic Ataxia Type‐2 are caused by mutations in the CA2+ channel gene CACNL1A4. Cell 87:543–552. [DOI] [PubMed] [Google Scholar]
102. Orozco G, Estrada R, Perry TL, Arana J, Fernandez R, Gonzalez‐Quevedo A, Galarraga J, Hansen S (1989) Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings. J. Neurol. Sci. 93:37–50. [DOI] [PubMed] [Google Scholar]
103. Orozco G, Nordarse A, Cordoves R, Auburger G (1990) Autosomal dominant cerebellar ataxia: clinical ananlysis of 263 patients from a homogeneous population in Holguin, Cuba. Neurology 40:1369–1375. [DOI] [PubMed] [Google Scholar]
104. Orr H, Chung M‐y, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL, McCall AE, Duvick LA, Ranum LPW, Zoghbi HY (1993) Expansion of an unstable trinucleotide (CAG) repeat in spinocerebellar ataxia type 1. Nature Genet. 4:221–226. [DOI] [PubMed] [Google Scholar]
105. Paulson HL, Das SS, Crino PB, Perez M, Patel SC, Gotsdiner D, Fischbeck KH, Pittman RN (1997) Machado‐Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Amer. Neur. Assoc. 41:453–462. [DOI] [PubMed] [Google Scholar]
106. Penrose LS (1948) The problem of anticipation in pedigrees of dystrophia myotonica. Ann Eugen (London) 14:125–232. [DOI] [PubMed] [Google Scholar]
107. Persichetti F, Ambrose CM, Ge P, McNeil SM, Srinidhi J, Anderson MA, Jenkins B, Barnes GT, Duyao MP, Kananley L (1995) Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat. Mol. Med. 1:374–383. [PMC free article] [PubMed] [Google Scholar]
108. Portera‐Cailliau C, Hedreen JC, Price DL, Koliatsos VE (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neuroscience 15:375–3787. [DOI] [PMC free article] [PubMed] [Google Scholar]
109. Potter NT, M.A. M , Zimmerman AW, Eisenstadt ML, Anderson IJ (1995) Molecular and clinical findings in a family with dentatorubral‐pallidoluysian atrophy. Ann Neur. 37:273–277. [DOI] [PubMed] [Google Scholar]
110. Pulst S‐M, Nechiporuk A, Nechiporuk T, Gisper S, Chen X‐N, Lopez‐Cendes I, Pearlman S, Lunkes A, DeJong P, Rouleau GA, Auburger G, Korenberg JR, Figueroa C, Sahba S (1996) Identification of the SCA2 gene: Moderate expansion of a normally biallelic trinucleotide repeat. Nature Genet. 14:269–276. [DOI] [PubMed] [Google Scholar]
111. Quan F, Janas J, Popovich BW (1995) A novel CAG repeat configuration in the SCA1 gene: implications for the molecular diagnostics of spinocerebellar ataxia type 1. Hum. Mol. Genet. 4:2411–2413. [DOI] [PubMed] [Google Scholar]
112. Quigley CA, Friedman KJ, Johnson A, Lafreniere RG, Silverman LM, Lubahn DB, Brown TR, Wilson EM, Wiilard HF, French FS (1992) Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J. clin. endocrinol. Metab. 74:927–933. [DOI] [PubMed] [Google Scholar]
113. Ranum LPW, Chung M‐y, Banfi S, Bryer A, Schut LJ, Ramesar R, Duvick LA, McCall AE, Subramony SH, Goldfarb L, Gomez C, Sandkuijl LA, Orr HT, Zoghbi HY (1994) Molecular and clinical correlations in spinocerebellar ataxia type 1 (SCA1): evidence for familial effects on the age of onset. Am. J. Hum. Genet. 55:244–252. [PMC free article] [PubMed] [Google Scholar]
114. Ringel SP, Lava NS, Treihaft MM, Lubs ML, Lubs HA (1978) Late onset X‐linked recessive spinal and bulbar muscular atrophy. Muscle & Nerve 1:297–307. [DOI] [PubMed] [Google Scholar]
115. Rodius F, Duclos F, Wrogemann K, Le Paslier D, Ougen P, Billault A, Belal S, Musenger C, Brice A, Durr A, Mignard C, Sirugo G, Weissenbach J, Cohen D, Hentati F, Ben Hamida M, Mandel J‐L, Koenig M (1994) Recombinations in individuals homozygous by descent localize the Friedreich ataxia locus in a cloned 450‐kb interval. Am. J. Hum. Genet. 54:1050–1059. [PMC free article] [PubMed] [Google Scholar]
116. Rommens JM, Lin B, Hutchinson GB, Andrew SE, Goldberg YP, Glaves ML, Graham R, Lai V, McArthur J, Nasir J, Kalchman M, Clarke LA, Schappert K, Hayden MR (1993) A transcription map of the region containing the Huntington disease gene. Hum. Mol. Genet. 2:901–907. [DOI] [PubMed] [Google Scholar]
117. Rosenberg RN, Nyhan WL, Bay C, Shore P (1976) Autosomal dominant striatonigral degeneration: a clinical, pathologic and biochemical study of a new genetic disorder. Neurology 26:703–714. [DOI] [PubMed] [Google Scholar]
118. Ross CA (1995) When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 15:493–496. [DOI] [PubMed] [Google Scholar]
119. Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman JJ, Chotai K, Connarty M, Crauford D, Curtis A, Curtis D, Davidson MJ, Differ AM, Dode C, Dodge A, Frontali M, Ranen NG, Stine OC, Sherr M, Abbott MH, Franz ML, Graham CA, Harper PS, Hedreen JC, Hayden MR, et al. (1996) Phenotypic characterization of individuals with 30–40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36–39 repeats. Amer. J. Hum. Genet. 59:16–22. [PMC free article] [PubMed] [Google Scholar]
120. Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T, Koide R, Saito M, Sato A, Tanaka T, Hanyu S, Takiyama Y, Nishizawa M, Shimizu N, Nomura Y, Segawa M, Iwabuchi K, Eguchi I, Tanaka H, Takahashi H, Tsuji S (1996) Identification of the gene for spinocerebellar ataxia type 2 (SCA2) using a direct identification of repeat expansion and cloning technique (DIRECT). Nature Genet. 14:277–284. [DOI] [PubMed] [Google Scholar]
121. Sar M, Stumpf WE (1977) Androgen concentration in motor nejrons of cranial nerves and spinal cord. Science 197:77–80. [DOI] [PubMed] [Google Scholar]
122. Sasaki H, Wakisaka A, Tashiro K, Hamada T, Katoh T (1992b) Linkage study of Machado‐Joseph disease: genetic evidence for the locus different from SCA1. Clin. Neruol. 32:13–16. [PubMed] [Google Scholar]
123. Schut JW (1950) Hereditary ataxia: clinical study through six generations. Arch. Neurol. Psychiatr. 63:535–568. [Google Scholar]
124. Schut JW, Haymaker W (1951) Hereditary ataxia. A pathologic study of five cases of common ancestry. J. Neuropath. Clin. Neurol. 1:183–213. [PubMed] [Google Scholar]
125. Schut LJ (1991) Schut family ataxia. In: de Jong JMBV (ed) Handbook of clinical neurology; Volume 16: Hereditary neuropathies and spinocerebellar atrophies. Elsevier, Amsterdam , pp 481–490. [Google Scholar]
126. Servadio A, Koshy B, Armstrong D, Antalfy B, Orr HT, Zoghbi HY (1995) Expression analysis of the ataxin‐1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nature Genet. 10:94–98. [DOI] [PubMed] [Google Scholar]
127. Sharp AH, Loev SJ, Schilling G, Li S‐H, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A, Hedreen J, Sisodia S, Snyder SH, Dawson TM, Ryugo DK, Ross CA (1995) Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14:1065–1074. [DOI] [PubMed] [Google Scholar]
128. Smith JK (1975) Dentatorubropallidoluysian atrophy. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. Vol. 21. North‐Holland, Amsterdam , pp 519–534. [Google Scholar]
129. Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nature Genet. 4:393–397. [DOI] [PubMed] [Google Scholar]
130. Spadaro M, Giunti P, Lulli P, Frontali M, Jodice C, Cappellacci S, Morellini M, Persichetti F, Trabace S, Anastasi R, Morocutti C (1992) HLA‐linked spinocerebellar ataxia: a clinical and genetic study of large Italian kindreds. Acta Neurol. Scand. 85:257–265. [DOI] [PubMed] [Google Scholar]
131. Starr TVB, Prystay W, Snutch TP (1991) Primary structure of a calcium channel that is highly expressed in the rat cerebellum. Proc. Natl. Acad. Sci, USA 88:5621–5625. [DOI] [PMC free article] [PubMed] [Google Scholar]
132. Stea A, Tomlinson WJ, Soong TW, Bourinet E, Dubel SJ, Vincent SR, Snutch TP (1994) Localization and functional properties of a rat brain a1A calcium channel reflect similarities to neuronal O‐ and P‐type channels. Proc. Natl. Acad. Sci. USA 91:10576–10580. [DOI] [PMC free article] [PubMed] [Google Scholar]
133. Stevanin G, Chneiweiss H, Le Guern E, Ravise N, Durr A, Penet C, Agid Y, Brice A (1993) Genetic heterogeneity of autosomal dominant cerebellar ataxia type I: evidence for the existence of a third locus. Hum. Mol. Genet. 2:1483–1485. [DOI] [PubMed] [Google Scholar]
134. Stine OC, Pleasant N, Franz ML, Abbott MH, Folstein SE, Ross CA (1993) Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in 11–15. Hum. Mol. Genet. 2:1547–1549. [DOI] [PubMed] [Google Scholar]
135. Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, Swaroop M, Kaatz KW, Collins FS, Albin RL (1993) Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genet. 5:259–265. [DOI] [PubMed] [Google Scholar]
136. Takahashi H, Ohama E, Naito H, Takeda S, Nakashima S, Makifuchi T, Ihuta F (1988) Hereditary dentatorubral‐pallidoluysian atrophy: Clinical and pathologic variants in a family. Neurology 38:1065–1070. [DOI] [PubMed] [Google Scholar]
137. Takiyama Y, Nishizawa M, Tanaka H, Kawashima S, Sakamoto H, Karube Y, Shimazaki H, Soutome M, Endo K, Ohta S, Kagawa Y, Kanazawa I, Mizuno Y, Yoshida M, Yuasa T, Horikawa Y, Oyanagi K, Nagai H, Kondo T, Inuzuka T, Onodera O, Tsuji S (1993) The gene for Machado‐Joseph disease maps to human chromosome 14q. Nature Genet. 4:300–303. [DOI] [PubMed] [Google Scholar]
138. Tanaka F, Doyu M, Ito Y, Matsumot M, Mitsuma T, Abe K, Aoki M, Itoyama Y, Fischbeck KH, Sobue G (1996) Founder effect in spinal and bulbar muscular atrophy (SBMA). Hum. Mol. Genet. 5:1253–1257. [DOI] [PubMed] [Google Scholar]
139. Telenius H, Kremer B, Goldberg YP, Theilmann J, Andrew SE, Zeisler J, Adam S, Greenberg C, Ives EJ, Clarke LA, Hayden MR (1994) Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat. Genet. 6:409–414. [DOI] [PubMed] [Google Scholar]
140. Telenius H, Kremer HPH, Theilmann J, Andrew SE, Almqvist E, Anyret M, Greenberg C, Greenberg J, Lucotte G, Squitieri F, Starr E, Goldberg YP, Hayden MR (1993) Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Hum. Mol. Genet. 2:1535–1540. [DOI] [PubMed] [Google Scholar]
141. Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA (1995) DNA end labeling (Tunel) in Huntington's disease and other neuropathological conditions. Exper. Neur. 133:265–272. [DOI] [PubMed] [Google Scholar]
142. Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y, Weber C, Agi Y, Hirsch EC, Mandel J‐L (1995) Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet. 10:104–110. [DOI] [PubMed] [Google Scholar]
143. Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L, Agid Y, Brice A, Mandel J‐L (1995) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378:403–406. [DOI] [PubMed] [Google Scholar]
144. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EPJ (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:559. [DOI] [PubMed] [Google Scholar]
145. Wanker EE, Rovira C, Scherzinger E, Hasenbank R, Walter S, Tait D, Colicelli J, Lehrach H (1997) HIP‐1: A huntingtin interacting protein isolated by the yeast two‐hybrid system. Hum. Mol. Genet. 6:487–495. [DOI] [PubMed] [Google Scholar]
146. Warner TT, Williams L, Harding AE (1994) DRPLA in Europe. Nature Genet, correspondence 6:225. [DOI] [PubMed] [Google Scholar]
147. Wexler NS (1979) Perceptual, motor, cognitive, and emotional characteristics of persons at risk for Huntington's disease. Adv. Neurol. 23:257–271. [Google Scholar]
148. Wood JD, MacMillan JC, Harper PS, Lowenstein PR, Jones AL (1995) Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain. Hum. Mol. Genet. 5:481–487. [DOI] [PubMed] [Google Scholar]
149. Yakura H, Wakisaka A, Fujimoto S, Itakura K (1974) Hereditary ataxia and HLA genotypes. New Engl. J. Med. 291:154–155. [DOI] [PubMed] [Google Scholar]
150. Yazawa I, Nukina N, Hashida H, Goto J, Yamada M, Kanazawai (1995) Abnormal gene product identified in hereditary dentatorubral‐pallidoluysian atrophy (DRPLA) brain. Nature Genet. 10:99–103. [DOI] [PubMed] [Google Scholar]
151. Zeitlin S, Liu J‐P, Chapman DL, Papaioannou VE, Efstratiadis A (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet. 11:155–163. [DOI] [PubMed] [Google Scholar]
152. Zhang JF, Randall AD, Ellinor PT, Home WA, Sather WA, Tanabe T, Schwarz TL, Tsien RW (1993) Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology 32:1075–1088. [DOI] [PubMed] [Google Scholar]
153. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton Dw, C. A , Dobyns WB, Subramony SH, Zoghbi HY, Lee C‐C (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the a1A‐voltage‐dependent calcium channel. Nature Genet. 15:62–69. [DOI] [PubMed] [Google Scholar]
154. Zoghbi HY (1996) The expanding world of ataxins. Nature Genet. 14:237–238. [DOI] [PubMed] [Google Scholar]
155. Zoghbi HY, Pollack MS, Lyons LA, Ferell RE, Daiger SP, Beaudet AL (1988) Spinocerebellar ataxia: variable age of onset and linkage to human leukocyte antigen in a large kindred. Ann. Neurol. 23:580–584. [DOI] [PubMed] [Google Scholar]
156. Zuhlke C, Riess O, Bockel B, Lange H, Thies U (1993) Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene. Hum. Mol. Genet. 2:2063–2067. [DOI] [PubMed] [Google Scholar]
157. Zuo J, Robbins C, Taillon‐Miller P, Cox DR, Myers RM (1992) Cloning of the Huntington disease region in yeast artificial chromosomes. Hum. Mol. Genet. 1:149–159. [DOI] [PubMed] [Google Scholar]

[b1] 1. Albin RL, Tagle DA (1995) Genetics and molecular biology of Huntington's disease. Trends Neurosci. 18:11–14. [DOI] [PubMed] [Google Scholar]

[b2] 2. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilman J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA, Graham RK, Hayden MR (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet. 4:398–403. [DOI] [PubMed] [Google Scholar]

[b3] 3. Arbizu T, Santamaria J, Gomez JM, Quilez A, Serra JP (1983) A family with adult spinal and bulbar muscular atrophy, X‐linked inheritance and associated testicular failure. J. Neurol Sci. 59:371–382. [DOI] [PubMed] [Google Scholar]

[b4] 4. Aronin N, Chase K, Young C, Sapp E, Schwarz C, Matta N, Kornreich R, Landwehrmeyer B, Bird E, Beal MF, Vonsattel J‐P, Smith T, Carraway R, Boyce FM, Young AB, Penney JB, DiFiglia M (1995) CAG Expansion Affects the Expression of Mutant Huntingtin in the Huntington's Disease Brain. Neuron 15:1193–1201. [DOI] [PubMed] [Google Scholar]

[b5] 5. Ashizawa T, Dubel JR, Dunne PW, Dunne CJ, Fu YH, Pizzuti A, Caskey CT, Boerwinkle E, Perryman MB, Epstein HF, Hejtmancik JF (1992) Anticipation in myotonic dystrophy: II. Complex relationships between clinical findings and structure of the GCT repeat. Neur. 42:1877–1883. [DOI] [PubMed] [Google Scholar]

[b6] 6. Ballabio A, Zoghbi HY (1995) Additional topics. In: Scriver CR, Beaudet AL, Sly WS, Valk D (eds) The metabolic basis of inherited disease. McGraw‐Hill, New York . [Google Scholar]

[b7] 7. Banfi S, Chung MY, Kwiatkowski TJ, Jr. , Ranum LP, McCall AE, Chinault AC, Orr HT, Zoghbi HY (1993) Mapping and cloning of the critical region for the spinocerebellar ataxia type 1 gene (SCA1) in a yeast artificial chromosome contig spanning 1.2 Mb. Genomics 18:627–635. [DOI] [PubMed] [Google Scholar]

[b8] 8. Banfi S, Servadio A, Chung M‐y, Kwiatkowski TJ Jr, McCall AE, Duvick LA, Shen Y, Roth EJ, Orr HT, Zoghbi HY (1994) Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nature Genet. 7:513–519. [DOI] [PubMed] [Google Scholar]

[b9] 9. Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM (1996) Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc. Natl. Acad. Sci USA 93:5037–42. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b10] 10. Barbeau A, Roy M, Cunha L, de Vincente AN, Rosenberg RN, Nyhan WL, MacLeod PM, et al (1984) The natural history of Machado‐Joseph disease: an analysis of 138 personally examined cases. Can. J. Neurol. Sci. 11:510–525. [DOI] [PubMed] [Google Scholar]

[b11] 11. Baxendale S, MacDonald ME, Mott R, Francis F, Lin C, Kirby SF, James M, Zehetner G, Hummerich H, Valdes J, Collins FS, Deaven LJ, Gusella JF, Lehrach H, Bates GP (1993) Acosmid contig and high resolution restriction map of the 2 megabase region containing the Huntington's disease gene. Nature Genet. 4:181–186. [DOI] [PubMed] [Google Scholar]

[b12] 12. Bebin EM, Bebin J, Currier RD, Smith EE, Perry TL (1990) Morphometric studies in dominant olivopontocerebellar atrophy. Arch. Neurol. 47:188–192. [DOI] [PubMed] [Google Scholar]

[b13] 13. Bharucha N, Bharucha E, Bhabha S (1986) Machado‐Joseph Azorean disease in India. Arch. Neurol. 43:142–144. [DOI] [PubMed] [Google Scholar]

[b14] 14. Biancalana V, Serville F, Pommier J, Julien J, Hanauer A, Mandel JL (1992) Moderate instability of the trinucleotide repeat in spinobulbar muscular atrophy. Hum. Mol. Genet. 1:255–258. [DOI] [PubMed] [Google Scholar]

[b15] 15. Bingham PM, Scott MO, Wang S, McPhaul MJ, Wilson EM, Garbern JY, Merry DE, Fischbeck KH (1995) Stability of an expanded trinucleotide repeat in the androgen receptor gene in trangenic mice. Nature Genet. 9:191–196. [DOI] [PubMed] [Google Scholar]

[b16] 16. Bird ED (1978) The brain in Huntington's chorea. Psycol. Med. 8:357–360. [DOI] [PubMed] [Google Scholar]

[b17] 17. Bozza A, Malagu S, Caizolari E, Novelletto A, Pavoni M, del Senno L (1995) Expansion of a (CAG)n repeat region in a sporadic case of HD. Acta Neurol Scand. 92:132. [DOI] [PubMed] [Google Scholar]

[b18] 18. Brown CJ, Goss SJ, Lubahn DB, Joseph DR, Wilson EM, French FS, Willard HT (1989) Androgen receptor locus on the X chromosome: Regional localization to Xq11–12 and description of a DNA polymorphism. Amer. J. Hum. Genet. 44:264–269. [PMC free article] [PubMed] [Google Scholar]

[b19] 19. Bruyn GW, Bots GTA, Dom R (1979) Huntington's chorea: Current neuropathological status. Adv. Neurol. 23:83–93. [Google Scholar]

[b20] 20. Burke JR, Enghild JJ, Martin ME, Jou Y‐S, Myers RM, Roses AD, Vance JM, Strittmatter WJ (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med. 2:347–350. [DOI] [PubMed] [Google Scholar]

[b21] 21. Burke JR, Wingfield MS, Lewis KE, Roses AD, Lee JE, Hulette C, Pericak‐Vance MA, Vance JM (1994) The Haw River Syndrome: Dentatorubropallidoluysian atrophy (DRPLA) in an African‐American family. Nature Genet. 7:521–524. [DOI] [PubMed] [Google Scholar]

[b22] 22. Burright EN, Clark HB, Servadio A, Matilla T, Feddersen RM, Yunis WS, Duvick LA, Zoghbi HY, Orr HT (1995) SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82:937–948. [DOI] [PubMed] [Google Scholar]

[b23] 23. Chang C, Kokontis J, Liao S (1988) Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc. Natl. Acad. Sci. USA 85:7211–7215. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b24] 24. Chong SS, McCall AE, Cota J, Subramony SH, Orr HT, Zoghbi HY (1995) Gametic and somatic tissue‐specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1. Nature Genet. 10:344–350. [DOI] [PubMed] [Google Scholar]

[b25] 25. Chung M‐y, Ranum LPW, Duvick L, Servadio A, Zoghbi HY, Orr HT (1993) Analysis of the CAG repeat expansion in spinocerebellar ataxia type I: evidence for a possible mechanism predisposing to instability. Nature Genet. 5:254–258. [DOI] [PubMed] [Google Scholar]

[b26] 26. Currier RD, Glover G, Jackson JF, Tipton AC (1972) Spinocerebellar ataxia: study of a large kindred. Neurology 22:1040–1043. [DOI] [PubMed] [Google Scholar]

[b27] 27. Davis MB, Bateman D, Quinn NP, Marsden CD, Harding AE (1994) Mutation analysis in patients with possible but apparently sporadic Huntington's disease. Lancet 344:714. [DOI] [PubMed] [Google Scholar]

[b28] 28. De Rooij KE, Dorsman JC, Smoor MA, Den Dunnen JT, Van Ommen G‐JB (1996) Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. Hum. Mol. Genet. 5:1093–1099. [DOI] [PubMed] [Google Scholar]

[b29] 29. DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C, Martin E, Vonsattel J‐P, Carraway R, Reeves SA, Boyce FM, Aronin N (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14:1075–1081. [DOI] [PubMed] [Google Scholar]

[b30] 30. Durr A, Dode C, Hahn V, Pecheux C, Pillon B, Feingold J, Kaplan JC, Agid Y, Brice A (1995) Diagnosis of “sporadic” Huntington's disease. J. Neurol. Sci. 129:51. [DOI] [PubMed] [Google Scholar]

[b31] 31. Durr A, Smadja D, Cancel G, Lezin A, Stevanin G, Mikol J, Bellance R, Buisson G‐G, Chneiweiss H, Dellanave J, Agid Y, Brice A, Vernant J‐C (1995) Autosomal dominant cerebellar ataxia type 1 in Martinique (French West Indies): Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 118:1573–1581. [DOI] [PubMed] [Google Scholar]

[b32] 32. Durr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, Chneiweiss H, Benomar A, Lyon‐Caen O, Julien J, Serdaru M, Penet C, Agid Y, Brice A (1996) Spinocerebellar ataxia 3 and machado‐joseph disease: Clinical, molecular and neuropathological features. Ann. Neurol. 39:490–499. [DOI] [PubMed] [Google Scholar]

[b33] 33. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M, Gray J, Conneally P, Young A, Penney J, Hollingsworth Z, Shoulson I, Lazzarini A, Falek A, Koroshetz W, Sax D, Bird E, Vonsattel J, Bonilla E, Alvir J, Bickham Conde J, Cha J‐H, Dure L, Gomez F, Ramos M, Sanchez‐Ramos J, Snodgrass S, de Young M, Eexler N, Moscowitz C, Penchaszadeh G, MacFarlene H, Anderson M, Jenkins B, Srinidhi J, Barnes G, Gusella J, MacDonald M (1993) Trinucleotide repeat length and age of onset in Huntington's disease. Nature Genet. 4:387–392. [DOI] [PubMed] [Google Scholar]

[b34] 34. Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McCeil SM, Ge P, Vonsattel J‐P, Gusella JF, Joyner AL, MacDonald ME (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269:407–410. [DOI] [PubMed] [Google Scholar]

[b35] 35. Farrer LA (1986) Suicide and attempted suicide in Huntington's disease: implication for preclinical testing of persons at risk. Am. J. Med. Genet. 24:305–311. [DOI] [PubMed] [Google Scholar]

[b36] 36. Farrer LA, Conneally PM (1987) Predictability of pheno‐type in Huntington's disease. Arch. Neurol. 44:109–113. [DOI] [PubMed] [Google Scholar]

[b37] 37. Fischbeck KH, Ionasescu V, Ritter AW, Ionasescu R, Davies K, Ball S, Bosch P, Burns T, Hausmanowa‐Petrusewicz I, Borkowska J, Ringel SP, Stern LZ (1986) Localization of the gene for X‐linked spinal muscular atrophy. Neurology 36:1595–1598. [DOI] [PubMed] [Google Scholar]

[b38] 38. Folstein SE (1989) Huntington's disease. John Hopkins University Press, Baltimore , Maryland . [Google Scholar]

[b39] 39. Gispert S, Lunkes A, Santos N, Orozco G, Ha‐Hao D, Ratzlaff T, Aguiar J, Torrens I, Heredero L, Brice A, Cancel G, Stevanin G, Vernant J‐C, Durr A, Lepage‐Lezin A, Belal S, Ben‐Hamida M, Pulst S, Rouleau G, Weissenbach J, LePaslier D, Kucherlapati R, Montgomery K, Fukui K, Auburger G (1995) Localization of the candidate gene D‐amino oxidase outside the refined I‐cM region of spinocerebellar ataxia 2. Amer. J. Hum. Genet. 57:972–975. [PMC free article] [PubMed] [Google Scholar]

[b40] 40. Gispert S, Twills R, Orozco G, Brice A, Weber J, Heredero L, Scheufler K, Riley B, Allotey R, Nothers C, Hillerman R, Lunkes A, Khati C, Stevanin G, Hernandez A, Magarino C, Klockgether T, Durr A, Chneiweiss H, Enczmann J, Farrall M, Beckmann J, Mullan M, Wernet P, Agid Y, Freund H‐J, Williamson R, Auburger G, Chamberlain S (1993) Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23–24.1. Nature Genet. 4:295–299. [DOI] [PubMed] [Google Scholar]

[b41] 41. Goldberg YP, Kalchman MA, Metzler M, Nasir J, Zeisler J, Graham R, Koide HB, O'Kusky J, Sharp AH, Ross CA, Jirik F, Hayden MR (1996) Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. Hum. Mol. Genet. 5:177–185. [DOI] [PubMed] [Google Scholar]

[b42] 42. Goldberg YP, Kremer B, Andrew SE, Theilmann J, Graham RK, Squitieri F, Telenius H, Adam S, Sajoo A, Starr E, et al. (1993) Molecular analysis of new mutations for huntington's disease: intermediate alleles and sex of. Nature Genet 5:174–9: 182. [DOI] [PubMed] [Google Scholar]

[b43] 43. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Bromm M, Kazemi‐Esfarjani P, Thornberry NA, Vaillancourt JP, Hayden MR (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13:442–9. [DOI] [PubMed] [Google Scholar]

[b44] 44. Greenfield JG (1954) The spino‐cerebellar degenerations. C. C. Thomas, Springfield , IL , pp 112. [Google Scholar]

[b45] 45. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971–983. [DOI] [PubMed] [Google Scholar]

[b46] 46. Gusella JF, MacDonald ME (1996) Pathogenic mechanism in Huntington's disease. Quan. Symp. Cold Spring Harbor In press. [Google Scholar]

[b47] 47. Gusella JF, MaoDonald ME, Ambrose CM, Duyao MP (1993) Molecular genetics of Huntington's disease. Arch. Neurol. 50:1157–1163. [DOI] [PubMed] [Google Scholar]

[b48] 48. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ortina K, Wallace MR, Sakaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB (1983) A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306:234–238. [DOI] [PubMed] [Google Scholar]

[b49] 49. Harding AE, Tromas PK, Baraitser M, Bradbury PG, Morgan‐Hughes JA, Ponsford JR (1982) X‐linked recessive bulbospinal neuronopathy: A report of ten cases. J. Neurol. Neurosurg. Psychiatry 45:1012–1019. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b50] 50. Harper PS (1989) Myotonic Dystrophy. In: Saunders WB (ed.) Vol. 2, London . [Google Scholar]

[b51] 51. Harper PS, Morris MJ, Quarrell O, Shaw DJ, Tyler A, Youngman S (1991) Huntington's disease. W.B. Saunders, Philadelphia . [Google Scholar]

[b52] 52. Hayden MR (1981) Huntington's chorea. Springer‐Verlag, New York . [Google Scholar]

[b53] 53. Hayden MR, Kremer B (1995) Huntington Disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease. Vol. III. McGraw‐Hill, Inc., New York , pp 4483–4510. [Google Scholar]

[b54] 54. Hayden MR, Soles JA, Ward RH (1985) Age of onset in siblings of persons with juvenile Huntington's disease. Clin. Genet. 28:100–105. [DOI] [PubMed] [Google Scholar]

[b55] 55. Hodgson JG, Smith DJ, McCutcheon K, Koide HG, Nishiyama K M.B. D, Stevens ME, Bissada N, Nasir J, Kanazawa I, Disteche CM, Rubin EM, M.R. H (1996) Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum. Mol. Genet. 5:1875–1885. [DOI] [PubMed] [Google Scholar]

[b56] 56. Hoogeveen AT, Willemsen R, Meyer N, de Rooij KE, Roos RAC, van Ommen G‐JB, Galjaard H (1993) Characterization and localization of the Huntington disease gene product. Hum. Mol. Genet. 2:2069–2073. [DOI] [PubMed] [Google Scholar]

[b57] 57. Höweler CJ, Busch HFM, Geraedts JPM, Niermeijer MF, Staal A (1989) Anticipation in myotonic dystrophy: fact or fiction. Brain 112:779–797. [DOI] [PubMed] [Google Scholar]

[b58] 58. Huntington G (1872) On chorea. Med. Surg. Reporter 26:317–321. [Google Scholar]

[b59] 59. Hyslop PS, Rogaeva E, Huterer J, Tsuda T, Santos J, Haines JL, Schlumpf K, Rogaev EI, Liang Y, McLachlan DR, Kennedy J, Weissenbach J, Billingsley GD, Cox DW, Lang AE, Wherrett JR (1994) Machado‐Joseph disease in pedigrees of Azorean descent is linked to chromosome 14. Am. J. Hum. Genet. 55:120–125. [PMC free article] [PubMed] [Google Scholar]

[b60] 60. Igarashi S, Tanno Y, Onodera O, Yamazaki M, Sato S, Ishikawa A, Miyatani N, Nagashima M, Ishikawa Y, Sahashi K, Ibi T, Miyatake T, Tsuji S (1992) Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology 42:2300–2302. [DOI] [PubMed] [Google Scholar]

[b61] 61. Ihara T, Sasaki H, Wakisaka A, Takada A, Yoshiro K (1994) Genetic heterogeneity of dominantly inherited olivopontocerebellar atrophy (OPCA) in the Japanese: linkage study of two pedigrees and evidence for the disease locus on chromosome 12q (SCA2). Human Genetics 39:305–313. [DOI] [PubMed] [Google Scholar]

[b62] 62. Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Gamier J‐M, Weber C, Mandel J‐L (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats and high instability. Nature Genet. 14:285–291. [DOI] [PubMed] [Google Scholar]

[b63] 63. Jackson JF, Currier RD, Terasaki PI, Morton NE (1977) Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N. Engl. J. Med. 296:1138–1141. [DOI] [PubMed] [Google Scholar]

[b64] 64. Jodice C, Malaspina P, Persichetti F, Novelletto A. Spadaro M, Giunti P, Morocutti C, Terrena'o L, Harding AE, Frontali M (1994) Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar ataxia 1. Amer. J. Hum. Genet. 54:959–965. [PMC free article] [PubMed] [Google Scholar]

[b65] 65. Jou YS, Myers RM (1995) Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum. Mol. Genet. 4:465–9. [DOI] [PubMed] [Google Scholar]

[b66] 66. Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, Goldberg YP, Gietz RD, Pickart CM, Hayden MR (1996) Huntingtin is ubiquitinated and interacts with a specific ubiquitin‐conjugating enzyme. J. Biol. Chem. 271: 19385–94. [DOI] [PubMed] [Google Scholar]

[b67] 67. Kalchman MA, Koide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K, Kazemi‐Esfarjani P, Lynn FC, Wellington C, Metzler M, Goldberg YP, Kanazawa I, Gietz RD, Hayden MR (1997) HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane‐associated huntingtin in the brain. Nature Genet. 16:44–53. [DOI] [PubMed] [Google Scholar]

[b68] 68. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I, Kimura J. Narumiya S, Kakizuka A (1994) CAG expansions in a novel gene for Machado‐Joseph disease at chromosome 14q32.1. Nature Genet. 8:221–227. [DOI] [PubMed] [Google Scholar]

[b69] 69. Kennedy WR, Alter M, Sung JH (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset ‐ A sex‐linked recessive trait. Neurology 18:671–680. [DOI] [PubMed] [Google Scholar]

[b70] 70. Koeppen AH, Barron KD (1984) The neuropathology of olivopontocerebellar atrophy. In: Duvoisin RC, Plaitakis A (eds) The olivopontocerebellar atrophies. Raven, New York , pp 13–38. [PubMed] [Google Scholar]

[b71] 71. Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, Takahashi H, Kondo R, Ishikawa A, Hayashi T, Saito M, Tomoda A, Miike T, Naito H, Ikuta F, Tsuji S (1994) Unstable expansion of CAG repeat in hereditary dentatorubral‐pallidoluysian atrophy (DRPLA). Nature Genet. 6:9–13. [DOI] [PubMed] [Google Scholar]

[b72] 72. Koshy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY (1996) Spinocerebellar ataxia type‐1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde‐3‐phosphate dehydrogenase. Hum. Mol. Genet. 5:1311–1318. [DOI] [PubMed] [Google Scholar]

[b73] 73. Kwiatkowski TJ Jr, Orr HT, Banfi S, McCall AE, Jodice C, Persichetti F, Novelletto A, LeBorgne‐Demarquoy F, Duvick LA, Frontali M, Subramony SH, Beaudet AL, Terrenato L, Zoghbi HY, Ranum LPW (1993) The gene for autosomal dominant spinocerebellar ataxia (SCA1) maps centromeric to D6S89 and shows no recombination, in nine large kindreds, with a dinucleotide repeat at the AM10 locus. Am. J. Hum. Genet. 53:391–400. [PMC free article] [PubMed] [Google Scholar]

[b74] 74. La Spada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa‐Petrusewicz I, Yee W‐C, Fischbeck KH (1992) Meiotic stability and genotype‐phenotype correlation of the trinucleotide repeat in X‐linked spinal and bulbar muscular atrophy. Nature Genet. 2:301–304. [DOI] [PubMed] [Google Scholar]

[b75] 75. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck H (1991) Androgen receptor gene mutations in X‐linked spinal and bulbar muscular atrophy. Nature 352:77–79. [DOI] [PubMed] [Google Scholar]

[b76] 76. Landwehrmeyer GB, McNeil SM, Dure LSt, Ge P, Aizawa H, Huang Q, Ambrose CM, Duyao MP, Bird ED, Bonilla E, et al. (1995) Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann. Neurol. 37:218–30. [DOI] [PubMed] [Google Scholar]

[b77] 77. Leeflang EP, Zhang L, Tavare S, Hubert R, Srinidhi J, MacDonald ME, Myers RH, de Young M, Wexler NS, Guseila JF, et al. (1995) Single sperm analysis of the trinucleotide repeats in the Huntington's disease gene: quantification of the mutation frequency spectrum. Hum. Mol. Genet. 4:1519–26. [DOI] [PubMed] [Google Scholar]

[b78] 78. Lezin A, Cancel G, Stevanin G, Smadja D, Vernant JC, Durr A, Martial J, Buisson GG, Bellance R, Chneiweiss H, Agid Y, Brice A (1996) Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): genetic analysis of three unrelated SCA2 families. Human Genetics 97:671–676. [DOI] [PubMed] [Google Scholar]

[b79] 79. Li S‐H, Schilling G, Young WSI, Li X‐J, Margolis RL, Stine OC, Wagster MV, Abbott MH, Franz ML, Ranen NG, Foistein SE, Hedreen JC, Ross CA (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11:985–993. [DOI] [PubMed] [Google Scholar]

[b80] 80. Li X‐J, Li S‐H, Sharp AH, Nucifora FCJ, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A hunt‐ingtin‐associated protein enriched in brain with implications for pathology. Nature 378:398–402. [DOI] [PubMed] [Google Scholar]

[b81] 81. Lopes‐Cendes I, Andermann E, Rouleau GA (1994) Evidence for the existence of a fourth dominantly inherited spinocerebellar ataxia locus. Genomics 21:270–274. [DOI] [PubMed] [Google Scholar]

[b82] 82. Lorenzetti D, Bohlega S, Zoghbi HY (1997) The expansion of the CAG repeat in the ataxin‐2 gene is a frequent cause of autosomal dominant spinocerebellar ataxia. Neurology (in press). [DOI] [PubMed] [Google Scholar]

[b83] 83. MacDonald ME, Barnes G, Srinidhi J, Duyao MP, Ambrose CM, Myers RH, Gray J, Connealy PM, Young A, Penney J, Shoulson J, Hollingsworth Z, Koroshetz W, Bird E, Vonsattel JP, Bonilla E, Moscowitz C, Penchaszadeh G, Brzustowicz L, Alvir J, Bickjam Conde J, Cha J‐H, Dure L, Gomez F, Ramos‐Arroyo M, Sanchez‐Ramos J, Snodgrass SR, de Young M, Wexler NS, MacFarlane H, Anderson MA, Jenkins B, Guseila JF (1993) Gametic but not somatic instability of CAG repeat length in Huntington's disease. J. Med. Genet. 30:982–986. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b84] 84. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, G.P. B (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493–506. [DOI] [PubMed] [Google Scholar]

[b85] 85. Martin JB, Guseila JF (1986) Huntington's disease: pathogenesis and management. N. Engl. J. Med. 315:1267–1276. [DOI] [PubMed] [Google Scholar]

[b86] 86. Maruyama H, Nakamura S, Matsuyama Z, Sakai T, Doyu M, Sobue G, Seto M, Tsujihata M, Oh‐i T, Nishio T, Sunohara N, Takahashi R, Hayashi M, Nishino I, Ohtake T, Oda T, Nishimura M, Saida T, Matsumoto H, Baba M, Kawaguchi Y, Kakizuka A, Kawakami H (1995) Molecular features of the CAG repeats and clinical manifestation of Machado‐Joseph disease. Hum. Mol. Genet. 4:807–812. [DOI] [PubMed] [Google Scholar]

[b87] 87. Matilla T, McCall A, Subramony SH, Zoghbi HY (1995) Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado‐Joseph disease. Ann. Neurol. 38:68–72. [DOI] [PubMed] [Google Scholar]

[b88] 88. Matilla T, Volpini V, Gem's D, Rosell J, Corral J, Davalos A, Molins A, Estivill X (1993) Presymptomatic analysis of spinocerebellar ataxia type 1 (SCA1) via the expansion of the SCA1 CAG‐repeat in a large pedigree displaying anticipation and parental male bias. Hum. Mol. Genet. 2:2123–2128. [DOI] [PubMed] [Google Scholar]

[b89] 89. Mhatre AN, Trifiro MA, Kaufman M, Kazemi‐Esfarjani P, Figlewicz D, Rouleau G, Pinsky L (1993) Reduced transcriptional regulatory competence of the androgen receptor in X‐linked spinal and bulbar muscular atrophy. Nature Genet. 5:184–188. [DOI] [PubMed] [Google Scholar]

[b90] 90. Miwa S (1994) Triplet repeats strike again. Nature Genet. news & views 6:3–4. [DOI] [PubMed] [Google Scholar]

[b91] 91. Myers RH, MacDonald ME, Koroshetz WJ, Duyao MP, Ambrose CM, Taylor SAM, Barnes G, Srinidhi J, Lin CS, Whaley WL, Lazzarini AM, Schwarz M, Wolff G, Bird ED, Vonsattel J‐PG, Guseila JF (1993) De novo expansion of a (CAG)n repeat in sporadic Huntington's disease. Nature Genet. 5:168–173. [DOI] [PubMed] [Google Scholar]

[b92] 92. Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, Takedo T, Tadokoro K, Kondo I, Muruyama N, Tanaka Y, Kikushima H, Umino K, Kurosawa H, Furukawa T, Nihei K, Inoue T, Sano A, Komure O, Takahashi M, Yoshizawa T, Kanazawa I, Yamada M (1994) Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genet. 6:14–18. [DOI] [PubMed] [Google Scholar]

[b93] 93. Naito H, Oyanagi S (1982) Familial myoclonus epilepsy and choreoathetosis: Hereditary dentatorubral‐pallidoluysian atrophy. Neurology 32:798–807. [DOI] [PubMed] [Google Scholar]

[b94] 94. Nakano KK, Dawson DM, Spence A (1972) Machado disease: A hereditary ataxia in Portuges emigrants to Massachusetts. Neurology 22:49–55. [DOI] [PubMed] [Google Scholar]

[b95] 95. Nance MA (1996) Huntington disease‐another chapter rewritten [editorial]. Amer. J. Hum. Genet. 59:1–6. [PMC free article] [PubMed] [Google Scholar]

[b96] 96. Nasir J, Floresco SB, O'Kusky JR, Diewert VM, Richman JM, Zeisler J, Borowski A, Marth JD, Phillips AG, Hayden MR (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morpholcgical changes in heterozygotes. Cell 81:811–823. [DOI] [PubMed] [Google Scholar]

[b97] 97. Nino HE, Noreen HJ, Dubey DP (1980) A family with hereditary ataxia: HLA typing. Neurology 30:12–20. [DOI] [PubMed] [Google Scholar]

[b98] 98. Norremolle A, Riess O, Epplen JT, Fenger K, Hasholt L, Sorensen SA (1993) Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families. Hum. Mol. Genet. 2:1475–1476. [DOI] [PubMed] [Google Scholar]

[b99] 99. Novelletto A, Persichetti F, Sabbadini G, Mandich P, Bellone E, Ajmar F, Pergola M, Del Senno L, MacDonald ME, Guseila JF, Frontali M (1994) Analysis of the trinucleotide repeat expansion in Italian families affected with Huntington disease. Hum. Mol. Genet. 3:93–98. [DOI] [PubMed] [Google Scholar]

[b100] 100. Onodera O, Oyake M, Takano H, Ikeuchi T, Igarashi S, Tsuji S (1995) Molecular cloning of a full‐length cDNA for dentatorubral‐pallidoluysian atrophy and regional expressions of the expanded alleles in the CNS. Am. J. Hum. Genet 57:1050–1060. [PMC free article] [PubMed] [Google Scholar]

[b101] 101. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SMG, Lamerdin JE, Mohrenweiser HW, De Bulman, Ferrari M, Haan J, Lindhout D, van Ommen G‐JB, Hofker MH, Ferrari MD, Frants RR (1996) Familial Hemiplegic Migraine and Episodic Ataxia Type‐2 are caused by mutations in the CA2+ channel gene CACNL1A4. Cell 87:543–552. [DOI] [PubMed] [Google Scholar]

[b102] 102. Orozco G, Estrada R, Perry TL, Arana J, Fernandez R, Gonzalez‐Quevedo A, Galarraga J, Hansen S (1989) Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings. J. Neurol. Sci. 93:37–50. [DOI] [PubMed] [Google Scholar]

[b103] 103. Orozco G, Nordarse A, Cordoves R, Auburger G (1990) Autosomal dominant cerebellar ataxia: clinical ananlysis of 263 patients from a homogeneous population in Holguin, Cuba. Neurology 40:1369–1375. [DOI] [PubMed] [Google Scholar]

[b104] 104. Orr H, Chung M‐y, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL, McCall AE, Duvick LA, Ranum LPW, Zoghbi HY (1993) Expansion of an unstable trinucleotide (CAG) repeat in spinocerebellar ataxia type 1. Nature Genet. 4:221–226. [DOI] [PubMed] [Google Scholar]

[b105] 105. Paulson HL, Das SS, Crino PB, Perez M, Patel SC, Gotsdiner D, Fischbeck KH, Pittman RN (1997) Machado‐Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Amer. Neur. Assoc. 41:453–462. [DOI] [PubMed] [Google Scholar]

[b106] 106. Penrose LS (1948) The problem of anticipation in pedigrees of dystrophia myotonica. Ann Eugen (London) 14:125–232. [DOI] [PubMed] [Google Scholar]

[b107] 107. Persichetti F, Ambrose CM, Ge P, McNeil SM, Srinidhi J, Anderson MA, Jenkins B, Barnes GT, Duyao MP, Kananley L (1995) Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat. Mol. Med. 1:374–383. [PMC free article] [PubMed] [Google Scholar]

[b108] 108. Portera‐Cailliau C, Hedreen JC, Price DL, Koliatsos VE (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neuroscience 15:375–3787. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b109] 109. Potter NT, M.A. M , Zimmerman AW, Eisenstadt ML, Anderson IJ (1995) Molecular and clinical findings in a family with dentatorubral‐pallidoluysian atrophy. Ann Neur. 37:273–277. [DOI] [PubMed] [Google Scholar]

[b110] 110. Pulst S‐M, Nechiporuk A, Nechiporuk T, Gisper S, Chen X‐N, Lopez‐Cendes I, Pearlman S, Lunkes A, DeJong P, Rouleau GA, Auburger G, Korenberg JR, Figueroa C, Sahba S (1996) Identification of the SCA2 gene: Moderate expansion of a normally biallelic trinucleotide repeat. Nature Genet. 14:269–276. [DOI] [PubMed] [Google Scholar]

[b111] 111. Quan F, Janas J, Popovich BW (1995) A novel CAG repeat configuration in the SCA1 gene: implications for the molecular diagnostics of spinocerebellar ataxia type 1. Hum. Mol. Genet. 4:2411–2413. [DOI] [PubMed] [Google Scholar]

[b112] 112. Quigley CA, Friedman KJ, Johnson A, Lafreniere RG, Silverman LM, Lubahn DB, Brown TR, Wilson EM, Wiilard HF, French FS (1992) Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J. clin. endocrinol. Metab. 74:927–933. [DOI] [PubMed] [Google Scholar]

[b113] 113. Ranum LPW, Chung M‐y, Banfi S, Bryer A, Schut LJ, Ramesar R, Duvick LA, McCall AE, Subramony SH, Goldfarb L, Gomez C, Sandkuijl LA, Orr HT, Zoghbi HY (1994) Molecular and clinical correlations in spinocerebellar ataxia type 1 (SCA1): evidence for familial effects on the age of onset. Am. J. Hum. Genet. 55:244–252. [PMC free article] [PubMed] [Google Scholar]

[b114] 114. Ringel SP, Lava NS, Treihaft MM, Lubs ML, Lubs HA (1978) Late onset X‐linked recessive spinal and bulbar muscular atrophy. Muscle & Nerve 1:297–307. [DOI] [PubMed] [Google Scholar]

[b115] 115. Rodius F, Duclos F, Wrogemann K, Le Paslier D, Ougen P, Billault A, Belal S, Musenger C, Brice A, Durr A, Mignard C, Sirugo G, Weissenbach J, Cohen D, Hentati F, Ben Hamida M, Mandel J‐L, Koenig M (1994) Recombinations in individuals homozygous by descent localize the Friedreich ataxia locus in a cloned 450‐kb interval. Am. J. Hum. Genet. 54:1050–1059. [PMC free article] [PubMed] [Google Scholar]

[b116] 116. Rommens JM, Lin B, Hutchinson GB, Andrew SE, Goldberg YP, Glaves ML, Graham R, Lai V, McArthur J, Nasir J, Kalchman M, Clarke LA, Schappert K, Hayden MR (1993) A transcription map of the region containing the Huntington disease gene. Hum. Mol. Genet. 2:901–907. [DOI] [PubMed] [Google Scholar]

[b117] 117. Rosenberg RN, Nyhan WL, Bay C, Shore P (1976) Autosomal dominant striatonigral degeneration: a clinical, pathologic and biochemical study of a new genetic disorder. Neurology 26:703–714. [DOI] [PubMed] [Google Scholar]

[b118] 118. Ross CA (1995) When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 15:493–496. [DOI] [PubMed] [Google Scholar]

[b119] 119. Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman JJ, Chotai K, Connarty M, Crauford D, Curtis A, Curtis D, Davidson MJ, Differ AM, Dode C, Dodge A, Frontali M, Ranen NG, Stine OC, Sherr M, Abbott MH, Franz ML, Graham CA, Harper PS, Hedreen JC, Hayden MR, et al. (1996) Phenotypic characterization of individuals with 30–40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36–39 repeats. Amer. J. Hum. Genet. 59:16–22. [PMC free article] [PubMed] [Google Scholar]

[b120] 120. Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T, Koide R, Saito M, Sato A, Tanaka T, Hanyu S, Takiyama Y, Nishizawa M, Shimizu N, Nomura Y, Segawa M, Iwabuchi K, Eguchi I, Tanaka H, Takahashi H, Tsuji S (1996) Identification of the gene for spinocerebellar ataxia type 2 (SCA2) using a direct identification of repeat expansion and cloning technique (DIRECT). Nature Genet. 14:277–284. [DOI] [PubMed] [Google Scholar]

[b121] 121. Sar M, Stumpf WE (1977) Androgen concentration in motor nejrons of cranial nerves and spinal cord. Science 197:77–80. [DOI] [PubMed] [Google Scholar]

[b122] 122. Sasaki H, Wakisaka A, Tashiro K, Hamada T, Katoh T (1992b) Linkage study of Machado‐Joseph disease: genetic evidence for the locus different from SCA1. Clin. Neruol. 32:13–16. [PubMed] [Google Scholar]

[b123] 123. Schut JW (1950) Hereditary ataxia: clinical study through six generations. Arch. Neurol. Psychiatr. 63:535–568. [Google Scholar]

[b124] 124. Schut JW, Haymaker W (1951) Hereditary ataxia. A pathologic study of five cases of common ancestry. J. Neuropath. Clin. Neurol. 1:183–213. [PubMed] [Google Scholar]

[b125] 125. Schut LJ (1991) Schut family ataxia. In: de Jong JMBV (ed) Handbook of clinical neurology; Volume 16: Hereditary neuropathies and spinocerebellar atrophies. Elsevier, Amsterdam , pp 481–490. [Google Scholar]

[b126] 126. Servadio A, Koshy B, Armstrong D, Antalfy B, Orr HT, Zoghbi HY (1995) Expression analysis of the ataxin‐1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nature Genet. 10:94–98. [DOI] [PubMed] [Google Scholar]

[b127] 127. Sharp AH, Loev SJ, Schilling G, Li S‐H, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A, Hedreen J, Sisodia S, Snyder SH, Dawson TM, Ryugo DK, Ross CA (1995) Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14:1065–1074. [DOI] [PubMed] [Google Scholar]

[b128] 128. Smith JK (1975) Dentatorubropallidoluysian atrophy. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. Vol. 21. North‐Holland, Amsterdam , pp 519–534. [Google Scholar]

[b129] 129. Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nature Genet. 4:393–397. [DOI] [PubMed] [Google Scholar]

[b130] 130. Spadaro M, Giunti P, Lulli P, Frontali M, Jodice C, Cappellacci S, Morellini M, Persichetti F, Trabace S, Anastasi R, Morocutti C (1992) HLA‐linked spinocerebellar ataxia: a clinical and genetic study of large Italian kindreds. Acta Neurol. Scand. 85:257–265. [DOI] [PubMed] [Google Scholar]

[b131] 131. Starr TVB, Prystay W, Snutch TP (1991) Primary structure of a calcium channel that is highly expressed in the rat cerebellum. Proc. Natl. Acad. Sci, USA 88:5621–5625. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b132] 132. Stea A, Tomlinson WJ, Soong TW, Bourinet E, Dubel SJ, Vincent SR, Snutch TP (1994) Localization and functional properties of a rat brain a1A calcium channel reflect similarities to neuronal O‐ and P‐type channels. Proc. Natl. Acad. Sci. USA 91:10576–10580. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b133] 133. Stevanin G, Chneiweiss H, Le Guern E, Ravise N, Durr A, Penet C, Agid Y, Brice A (1993) Genetic heterogeneity of autosomal dominant cerebellar ataxia type I: evidence for the existence of a third locus. Hum. Mol. Genet. 2:1483–1485. [DOI] [PubMed] [Google Scholar]

[b134] 134. Stine OC, Pleasant N, Franz ML, Abbott MH, Folstein SE, Ross CA (1993) Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in 11–15. Hum. Mol. Genet. 2:1547–1549. [DOI] [PubMed] [Google Scholar]

[b135] 135. Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, Swaroop M, Kaatz KW, Collins FS, Albin RL (1993) Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genet. 5:259–265. [DOI] [PubMed] [Google Scholar]

[b136] 136. Takahashi H, Ohama E, Naito H, Takeda S, Nakashima S, Makifuchi T, Ihuta F (1988) Hereditary dentatorubral‐pallidoluysian atrophy: Clinical and pathologic variants in a family. Neurology 38:1065–1070. [DOI] [PubMed] [Google Scholar]

[b137] 137. Takiyama Y, Nishizawa M, Tanaka H, Kawashima S, Sakamoto H, Karube Y, Shimazaki H, Soutome M, Endo K, Ohta S, Kagawa Y, Kanazawa I, Mizuno Y, Yoshida M, Yuasa T, Horikawa Y, Oyanagi K, Nagai H, Kondo T, Inuzuka T, Onodera O, Tsuji S (1993) The gene for Machado‐Joseph disease maps to human chromosome 14q. Nature Genet. 4:300–303. [DOI] [PubMed] [Google Scholar]

[b138] 138. Tanaka F, Doyu M, Ito Y, Matsumot M, Mitsuma T, Abe K, Aoki M, Itoyama Y, Fischbeck KH, Sobue G (1996) Founder effect in spinal and bulbar muscular atrophy (SBMA). Hum. Mol. Genet. 5:1253–1257. [DOI] [PubMed] [Google Scholar]

[b139] 139. Telenius H, Kremer B, Goldberg YP, Theilmann J, Andrew SE, Zeisler J, Adam S, Greenberg C, Ives EJ, Clarke LA, Hayden MR (1994) Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat. Genet. 6:409–414. [DOI] [PubMed] [Google Scholar]

[b140] 140. Telenius H, Kremer HPH, Theilmann J, Andrew SE, Almqvist E, Anyret M, Greenberg C, Greenberg J, Lucotte G, Squitieri F, Starr E, Goldberg YP, Hayden MR (1993) Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Hum. Mol. Genet. 2:1535–1540. [DOI] [PubMed] [Google Scholar]

[b141] 141. Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA (1995) DNA end labeling (Tunel) in Huntington's disease and other neuropathological conditions. Exper. Neur. 133:265–272. [DOI] [PubMed] [Google Scholar]

[b142] 142. Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y, Weber C, Agi Y, Hirsch EC, Mandel J‐L (1995) Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet. 10:104–110. [DOI] [PubMed] [Google Scholar]

[b143] 143. Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L, Agid Y, Brice A, Mandel J‐L (1995) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378:403–406. [DOI] [PubMed] [Google Scholar]

[b144] 144. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EPJ (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:559. [DOI] [PubMed] [Google Scholar]

[b145] 145. Wanker EE, Rovira C, Scherzinger E, Hasenbank R, Walter S, Tait D, Colicelli J, Lehrach H (1997) HIP‐1: A huntingtin interacting protein isolated by the yeast two‐hybrid system. Hum. Mol. Genet. 6:487–495. [DOI] [PubMed] [Google Scholar]

[b146] 146. Warner TT, Williams L, Harding AE (1994) DRPLA in Europe. Nature Genet, correspondence 6:225. [DOI] [PubMed] [Google Scholar]

[b147] 147. Wexler NS (1979) Perceptual, motor, cognitive, and emotional characteristics of persons at risk for Huntington's disease. Adv. Neurol. 23:257–271. [Google Scholar]

[b148] 148. Wood JD, MacMillan JC, Harper PS, Lowenstein PR, Jones AL (1995) Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain. Hum. Mol. Genet. 5:481–487. [DOI] [PubMed] [Google Scholar]

[b149] 149. Yakura H, Wakisaka A, Fujimoto S, Itakura K (1974) Hereditary ataxia and HLA genotypes. New Engl. J. Med. 291:154–155. [DOI] [PubMed] [Google Scholar]

[b150] 150. Yazawa I, Nukina N, Hashida H, Goto J, Yamada M, Kanazawai (1995) Abnormal gene product identified in hereditary dentatorubral‐pallidoluysian atrophy (DRPLA) brain. Nature Genet. 10:99–103. [DOI] [PubMed] [Google Scholar]

[b151] 151. Zeitlin S, Liu J‐P, Chapman DL, Papaioannou VE, Efstratiadis A (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet. 11:155–163. [DOI] [PubMed] [Google Scholar]

[b152] 152. Zhang JF, Randall AD, Ellinor PT, Home WA, Sather WA, Tanabe T, Schwarz TL, Tsien RW (1993) Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology 32:1075–1088. [DOI] [PubMed] [Google Scholar]

[b153] 153. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton Dw, C. A , Dobyns WB, Subramony SH, Zoghbi HY, Lee C‐C (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the a1A‐voltage‐dependent calcium channel. Nature Genet. 15:62–69. [DOI] [PubMed] [Google Scholar]

[b154] 154. Zoghbi HY (1996) The expanding world of ataxins. Nature Genet. 14:237–238. [DOI] [PubMed] [Google Scholar]

[b155] 155. Zoghbi HY, Pollack MS, Lyons LA, Ferell RE, Daiger SP, Beaudet AL (1988) Spinocerebellar ataxia: variable age of onset and linkage to human leukocyte antigen in a large kindred. Ann. Neurol. 23:580–584. [DOI] [PubMed] [Google Scholar]

[b156] 156. Zuhlke C, Riess O, Bockel B, Lange H, Thies U (1993) Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene. Hum. Mol. Genet. 2:2063–2067. [DOI] [PubMed] [Google Scholar]

[b157] 157. Zuo J, Robbins C, Taillon‐Miller P, Cox DR, Myers RM (1992) Cloning of the Huntington disease region in yeast artificial chromosomes. Hum. Mol. Genet. 1:149–159. [DOI] [PubMed] [Google Scholar]

PERMALINK

The CAG/Polyglutamine Tract Diseases: Gene Products and Molecular Pathogenesis

Beena T Koshy

Huda Y Zoghbi

Abstract

Full Text

References

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

The CAG/Polyglutamine Tract Diseases: Gene Products and Molecular Pathogenesis

Beena T Koshy

Huda Y Zoghbi

Abstract

Full Text

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases